Clinical Trials on Minimal Disease, Residual in Taiwan

Total 9569 results

NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Completed

NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Locally Advanced and Metastatic Pancreatic Cancer

Taiwan, Singapore
AstraZeneca

Completed

Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients

Non Small Cell Lung Cancer

Taiwan
Daiichi Sankyo, Inc.

Terminated

DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study

Covid19 Vaccine

Taiwan
Polaris Group

Completed

PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy

Non-Hodgkin's Lymphoma

Taiwan
Chiayi Christian Hospital
National Taiwan University Hospital; Mackay Memorial Hospital; National Cheng-Kung... and other collaborators

Recruiting

Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment (SHOT)

HepatoCellular Carcinoma

Taiwan
PhytoHealth Corporation

Terminated

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Quality of Life | Fatigue | Complementary

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Recruiting

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors,Gastroenteropancreatic

Taiwan
Hoffmann-La Roche

Completed

An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer

Colorectal Cancer

Taiwan
Galderma R&D

Completed

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

Psoriasis

Taiwan
PharmaEngine

Completed

Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer

Pancreatic Neoplasms

Taiwan, United States
Eisai Inc.

Completed

A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

Epilepsy

China
Shanghai Jiao Tong University Affiliated Sixth...
Chugai Pharma China Co., Ltd.

Recruiting

Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis (EFFECT)

Postmenopausal Osteoporosis | Low Bone Mineral Density

China
Genta Incorporated

Unknown

Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer (TESEGAST)

Gastric Carcinoma

Taiwan, United States, Germany
AstraZeneca

Completed

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

Carcinoma, Non-Small-Cell Lung

Taiwan
Taiwan Resonant Waves Research Corporation

Completed

Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Taiwan
SciClone Pharmaceuticals International (Cayman)...
Parexel; National Cheng-Kung University Hospital

Unknown

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

Non-Small Cell Lung Cancer | Advanced Solid Tumor

Taiwan
E-DA Hospital
Gilead Sciences; Taipei Institute of Pathology

Completed

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Chronic Hepatitis B

Taiwan
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Recruiting

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

Biliary Tract Cancer (BTC)

Taiwan
TaiRx, Inc.

Terminated

CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Advanced Cancer

Taiwan, United States
Chimei Medical Center

Completed

Online Mindfulness Therapy for Pandemic Fatigue and Resilience in COVID-19 Nurses

Resilience | Mindfulness | Nurses in COVID-19 | Pandemic Fatigue

Taiwan
National Taiwan University Hospital
National Cheng-Kung University Hospital; Far Eastern Memorial Hospital; Tri-Service... and other collaborators

Terminated

Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Patients Who Have Received Allo-HSCT

Taiwan
Johnson & Johnson Taiwan Ltd

Completed

A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

Multiple Myeloma

Taiwan
Taipei Medical University WanFang Hospital
Buddhist Tzu Chi General Hospital; Taichung Veterans General Hospital; Chang-Hua... and other collaborators

Active, not recruiting

Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis

Pulmonary Tuberculosis Confirmation by Culture

Taiwan
Taipei Veterans General Hospital, Taiwan

Unknown

Study in Asia of the Combination of TACE With Sorafenib in HCC Patients (START)

Hepatocellular Carcinoma

Taiwan
AstraZeneca

Completed

Brilinta Taiwan Post Approval Safety Study

Non ST-elevation Myocardial Infarction

Taiwan
Merck KGaA, Darmstadt, Germany

Completed

A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing Treatment

Metastatic Colorectal Cancer

Taiwan
Hoffmann-La Roche

No longer available

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Postmenopausal Osteoporosis

Taiwan
Boehringer Ingelheim

Completed

Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters

Hypertension

Taiwan
Bayer

Completed

Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

China, Taiwan
GlaxoSmithKline

Completed

Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer

Carcinoma, Hepatocellular

Taiwan, Thailand, Hong Kong
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (COVID-19)

Covid19 Vaccine

Taiwan, Vietnam
Lukas Biomedical Inc.
Virginia Contract Research Organization Co., Ltd.

Recruiting

Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan
Antengene Therapeutics Limited

Terminated

A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma (TEACH)

Solid Tumor, Non-Hodgkin's Lymphoma

China, Taiwan
National Health Research Institutes, Taiwan

Recruiting

A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma

Primary Malignant Brain Tumors

Taiwan
Polaris Group

Recruiting

Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

Nonalcoholic Steatohepatitis (NASH)

Taiwan
Ferring Pharmaceuticals

Completed

A Study of Degarelix in Taiwanese Patients With Prostate Cancer

Prostate Cancer

Taiwan
Johnson & Johnson Taiwan Ltd

Completed

An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

Taiwan
National Health Research Institutes, Taiwan

Recruiting

The Research Plan of Taiwan Precision Medicine

Non-small-cell Lung Cancer

Taiwan
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
TaiwanJ Pharmaceuticals Co., Ltd

Terminated

Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies (JKB122)

Chronic Hepatitis C

Taiwan
United Biomedical Inc., Asia
Vaxxinity, Inc.

Terminated

A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers

COVID-19

Taiwan
AstraZeneca

Completed

To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia

Hyperlipidemias

Taiwan
National Taiwan University Hospital

Recruiting

Taiwan Center of Outcome and Resource Evaluation

Critical Illness

Taiwan
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
CytoPharm, Inc.

Completed

Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment

Influenza A Virus Infection

Taiwan
Hoffmann-La Roche

Completed

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Liver Cancer

Philippines, Korea, Republic of, Taiwan
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection

Hepatitis C Virus Infection

Taiwan
Daiichi Sankyo, Inc.
AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...

Active, not recruiting

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

HER2-Positive Primary Breast Cancer | Residual Invasive Breast Cancer

United States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

Gastric Cancer

Taiwan
AstraZeneca

Completed

Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

Type II Diabetes Mellitus

Taiwan

Clinical Trials on Minimal Disease, Residual in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations